As those in the reproductive health space scramble to keep up with the ever-changing landscape of mifepristone (Mifeprex) access, it seems that every party must have their say. .
Reproductive health care and mifepristone Mifeprex access. Updates from DOJ, USPS, five letters signed by 40 state attorneys general, announcements from CVS and Walgreens, tweet by CA Governor Newsom, and movement in Texas case challenging FDA approval of mifepristone.
With approval of modified mifepristone Risk Evaluation and Mitigation Strategy REMS, it has been momentous time for reproductive health law. REMS are designed to reinforce medication use behaviors and actions that support the safe use of that medication.
With the approval of the modified mifepristone Risk Evaluation and Mitigation Strategy (REMS), it has been a momentous few weeks in the reproductive health legal space. .